Table 2.
Treatments, complications, and outcomes of patients with and without myocardial injury
| Total (n = 353) | Without myocardial injury (n = 274) | With myocardial injury (n = 79) | P value | |
|---|---|---|---|---|
| Treatments | ||||
| Antiviral treatment | 325 (92.1) | 260 (94.9) | 65 (82.3) | <0.01 |
| Antibiotics | 271 (76.8) | 198 (72.3) | 73 (92.4) | <0.01 |
| Corticosteroids | 62 (17.6) | 24 (8.8) | 38 (48.1) | <0.01 |
| Intravenous immunoglobulin | 44 (12.5) | 18 (6.6) | 26 (32.9) | <0.01 |
| Chinese medicine | 256 (72.5) | 218 (79.6) | 38 (48.1) | <0.01 |
| Nasal cannula oxygen therapy | 240 (68.0) | 188 (68.6) | 52 (65.8) | 0.64 |
| Mask oxygen inhalation | 36 (10.2) | 16 (5.8) | 20 (25.3) | <0.01 |
| High‐flow nasal cannula oxygen therapy | 14 (4.0) | 2 (0.7) | 12 (15.2) | <0.01 |
| Non‐invasive mechanical ventilation | 29 (8.2) | 3 (1.1) | 26 (32.9) | <0.01 |
| Invasive mechanical ventilation | 26 (7.4) | 2 (0.7) | 24 (30.4) | <0.01 |
| Circulatory support | 11 (3.1) | 0 (0.0) | 11 (13.9) | <0.01 |
| Renal replacement therapy | 11 (3.1) | 0 (0.0) | 11 (13.9) | <0.01 |
| Complications | ||||
| Respiratory failure | 57 (16.1) | 8 (2.9) | 49 (62.0) | <0.01 |
| Acute liver damage | 92 (26.1) | 51 (18.6) | 41 (51.9) | <0.01 |
| Acute kidney injury | 53 (15.0) | 14 (5.1) | 39 (49.4) | <0.01 |
| Septic shock | 20 (5.7) | 2 (0.7) | 18 (22.8) | <0.01 |
| MODS | 46 (13.0) | 0 (0.0) | 46 (58.2) | <0.01 |
| Coagulopathy | 18 (5.1) | 5 (1.8) | 13 (16.5) | <0.01 |
| Outcomes | <0.01 | |||
| Recovery | 267 (75.6) | 239 (87.2) | 28 (35.4) | |
| Improvement | 35 (9.9) | 31 (11.3) | 4 (5.1) | |
| Stabilization | 1 (0.3) | 0 (0.0) | 1 (1.3) | |
| Aggravation | 1 (0.3) | 0 (0.0) | 1 (1.3) | |
| Death | 49 (13.9) | 4 (1.5) | 45 (57.0) | |
ARDS, acute respiratory distress syndrome; MODS, multiple organ dysfunction syndrome.